Literature DB >> 19120380

Psychosocial consequences of genetic counseling: a population-based follow-up study.

Ellen M Mikkelsen1, Lone Sunde, Christoffer Johansen, Søren P Johnsen.   

Abstract

We aimed to examine the psychosocial impact of genetic counseling for hereditary breast and ovarian cancer 1 year following genetic counseling. We conducted a population-based prospective follow-up study of 213 women who received genetic counseling for hereditary breast and ovarian cancer, 319 women who underwent mammography (Reference Group I), and a random sample of 1,070 women from the general population (Reference Group II). The prevalence of anxiety decreased by 4.7% (95% CI: -3.5; 12.8) from baseline to 1 year of follow-up in the Genetic Counseling Group. Likewise, it decreased by 2.5% (95% CI: -4.5; 9.5) in Reference Group I and by 1.1% (95% CI: -2.3; 4.7) in Reference Group II. The prevalence of depression increased equally (1-3%) in the three study groups. 52% of the women referred for genetic counseling experienced cancer-specific distress at baseline and this proportion decreased to 41% after 12 months of follow-up. This decrease of 10.8% (95% CI: 1.4; 20.8) exceeded the decrease observed in both Reference Groups. However, it was statistically significant only in the case of Reference Group II (p=0.006). Our findings indicate that genetic counseling can help alleviate cancer-specific distress among women with a family history of breast and ovarian cancer. Further, genetic counseling does not appear to have an adverse impact on general anxiety, symptoms of depression, or health-related quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 19120380     DOI: 10.1111/j.1524-4741.2008.00672.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  8 in total

1.  Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.

Authors:  A R Bradbury; L Patrick-Miller; D Fetzer; B Egleston; S A Cummings; A Forman; L Bealin; C Peterson; M Corbman; J O'Connell; M B Daly
Journal:  Clin Genet       Date:  2010-10-12       Impact factor: 4.438

2.  Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.

Authors:  Marcos Ricardo Datti Micheletto; Nelson Iguimar Valerio; Agnes Cristina Fett-Conte
Journal:  J Genet Couns       Date:  2013-06-23       Impact factor: 2.537

3.  Anticipating the arrival of low-penetrance genetic testing to primary care medicine.

Authors:  Beth A Tarini; Nicole Exe; Brian J Zikmund-Fisher
Journal:  J Community Genet       Date:  2013-02-12

4.  "Where Does it Come from?" Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya.

Authors:  Amal Gedleh; Siwon Lee; Jessica A Hill; Yvonne Umukunda; Seemi Qaiser; Joy Kabiru; Kahaki Kimani; Lucy Njambi; Grace Kitonyi; Helen Dimaras
Journal:  J Genet Couns       Date:  2017-11-23       Impact factor: 2.537

Review 5.  Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).

Authors:  Linda Patrick-Miller; Angela R Bradbury; Mary Beth Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

6.  Distress and psychosocial needs of a heterogeneous high risk familial cancer population.

Authors:  Tara E Power; John W Robinson; Peter Bridge; Francois P Bernier; Dawna M Gilchrist
Journal:  J Genet Couns       Date:  2011-04-21       Impact factor: 2.537

7.  Knowledge, experiences and attitudes concerning genetics among retinoblastoma survivors and parents.

Authors:  Jessica A Hill; Amal Gedleh; Siwon Lee; Kaitlyn A Hougham; Helen Dimaras
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

8.  Oncology Advanced Practitioners and Breast Cancer Prevention.

Authors:  Wendy H Vogel; Haley Pace; Matthew Brignola
Journal:  J Adv Pract Oncol       Date:  2020-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.